What payment terms are accepted?

Accepted terms include LC, T/T, D/P, Western Union, and Money Gram.

Infant Neonate Baby Jaundice Phototherapy Unit

Name: Infant Neonate Baby Jaundice Phototherapy Unit
Brand: Qingdao Aost Medical Manufacture Co., Ltd.
SKU: 697468182

Shandong, ChinaQingdao Aost Medical Manufacture Co., Ltd.

US$500.00-2,000.00

1 Piece

Product profile

Customization

Available

Code

Zzdshdzly001

Transport Package

Carton

Model NO.

SC-ZZDSHDZL

Specification

Trademark

SURE CARE

Origin

China

HS Code

9018

Production Capacity

50000

Key features

Dual Phototherapy Effect: Delivers double phototherapy effect at half the cost, saving on lamps and hospital stay time.

Fanless Quiet Operation: Features 5 tube fluorescent lights with no fan noise, ensuring a quiet environment for the baby.

Adjustable Height Stand: Comes with a stand on castors for functional placement, adjustable from 1200mm to 1500mm.

Integral Usage Timer: Includes an attached timer to count total hours of usage, ranging from 0 to 999h 59min.

Safe Neonatal Treatment: Specifically designed for neonatal jaundice treatment to avoid brain damage when bilirubin levels are high.

Company profile

Importers and ExportersFast DeliveryCustomization from Designs

Qingdao Aost Medical Manufacture Co., Ltd.

Shandong, China

Business Type: Manufacturer/FactoryExport Year: 2001-02-08Nearest Port: qingdaoAverage Response Time: ≤15hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, FCA, EXW

AI-Powered supplier vetting

SummaryQingdao Aost Medical Manufacture Co., Ltd. is identified as a Chinese manufacturer/factory and foreign joint venture operating in health and medicine and chemicals. Its stated activities include medical distribution, product and process quality management, electronic and mechanical equipment sales, technical glass manufacturing, and related product categories. The supplier offers design-based customization and reports that 90% of total sales are exports, with four years of export experience and self-operated import/export rights. However, the provided information shows no new products launched in the past year, unknown raw-material traceability, no overseas showroom, agents, branches, or offline trade-show participation, and insufficient evidence to assess financial strength or customer cases. An audit by TUV Rheinland is documented for the period from February 28, 2025 to February 27, 2026, but the audit result is recorded as 0 without an explanatory interpretation.

Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory located in Qingdao, Shandong, China, and is organized as a foreign joint venture. Its stated commercial sectors include Health & Medicine and Chemicals, consistent with its medical manufacturing positioning.

After-Sales capabilityThe company states that it provides sales and service activities specialized in the medical field. At the same time, it reports no overseas showroom, overseas agents or branches, overseas service countries, or offline trade-show participation, indicating limited documented overseas service infrastructure.

R&D capabilityThe supplier explicitly reports no new products launched during the past year. Although it offers customization from designs, the available evidence does not demonstrate recent product innovation or development output.

Production capacityThe supplier is identified as a manufacturer and reports quality assurance and process/product control activities. Its listed scope includes technical glass manufacturing and sales of medical, electronic, mechanical, rubber, chemical, packaging, and related products, supporting broad production and product-handling capability, though no capacity, equipment, workforce, or output figures are provided.

Customization capabilityThe supplier explicitly states “Customization from Designs,” which directly supports an ability to provide design-based customization. No further information is provided on engineering resources, minimum quantities, tooling, or customization limits.